Newly Synthesized Anti-Cancer Agent Much Powerful Than Taxol Drug

Trioxacarcins, a new form of cancer-killing compounds were discovered in the fermentation broth of the bacterial strain Streptomyces bottropensis.

A new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria has been developed by a team led by Rice University synthetic organic chemist K.C. Nicolaou.

The Nicolaou lab finds ways to replicate rare, naturally occurring compounds in larger amounts so they can be studied by biologists and clinicians as potential new medications. It also seeks to fine-tune the molecular structures of these compounds through analog design and synthesis to improve their disease-fighting properties and lessen their side effects.

Biosynthesis of Potent Anti-cancer Drug Taxol Advanced
A new way to biosynthesize important precursors to the potent anti-cancer compound Taxol in an engineered strain of E. coli bacteria has been revealed by researchers

‘New series of anti-cancer agents called Trioxacarcins, synthesized from a bacterial strain damage the cancer cells by altering their DNA. ’

Such is the case with their synthesis of trioxacarcins, reported this month in the Journal of the American Chemical Society.

"Not only does this synthesis render these valuable molecules readily available for biological investigation, but it also allows the previously unknown full structural elucidation of one of them. The newly developed synthetic technologies will allow us to construct variations for biological evaluation as part of a program to optimize their pharmacological profiles," Nicolaou said.

At present, there are no drugs based on trioxacarcins, which damage DNA through a novel mechanism, Nicolaou said.

Fungi Study may Lead to Cheaper Anti-Cancer Drug
This is the first study to show how fungi living naturally in yew trees serve as a combination bandage-immune system for the plant.

Trioxacarcins were discovered in the fermentation broth of the bacterial strain Streptomyces bottropensis. They disrupt the replication of cancer cells by binding and chemically modifying their genetic material.

"These molecules are endowed with powerful anti-tumor properties," Nicolaou said. "They are not as potent as shishijimicin, which we also synthesized recently, but they are more powerful than taxol, the widely used anti-cancer drug. Our objective is to make it more powerful through fine-tuning its structure."

Hope of New Tailor-Made Anti-Cancer Agents Triggered by New Discovery
A new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients has been customized by scientists.

He said his lab is working with a biotechnology partner to pair these cytotoxic compounds (called payloads) to cancer cell-targeting antibodies through chemical linkers. The process produces so-called antibody-drug conjugates as drugs to treat cancer patients. "It's one of the latest frontiers in personalized targeting chemotherapies," said Nicolaou, who earlier this year won the prestigious Wolf Prize in Chemistry.

Source-Newswise

Novel Anti-Cancer Agents Possible Via Antibiotic
An antibiotic known for its immunosuppressive functions could also point the way to the development of new anti-cancer agents, researchers at the Indiana University School of Medicine have reported.